Credit Suisse’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $54.5K | Sell |
|
|||||
|
2023
Q2 | $209K | Buy |
|
|||||
|
2023
Q1 | $335K | Buy |
|
|||||
|
2022
Q4 | $300K | Sell |
|
|||||
|
2022
Q3 | $167K | Buy |
|
|||||
|
2022
Q2 | $185K | Sell |
|
|||||
|
2022
Q1 | $303K | Buy |
|
|||||
|
2021
Q4 | $276K | Buy |
|
|||||
|
2021
Q3 | $410K | Buy |
|
|||||
|
2021
Q2 | $361K | Hold |
|
|||||
|
2021
Q1 | $537K | Sell |
|
|||||
|
2020
Q4 | $2.25M | Sell |
|
|||||
|
2020
Q3 | $2.57M | Buy |
|
|||||
|
2020
Q2 | $2.54M | Buy |
|